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Ubjectives, This study sought to characterize the Functional 
properties of decremental accessory atrioventricular (AV) path- 
ways and to investigate :beir pharmacologic responses. 
Backsrr~und. Mbough decremental AV pathways associated 
with incessant reciprocating taebycardia have been studied exten- 
sively, information about the etectrophysiologic haracteristics 
and pharmacologic responses of anterograde and retrograde 
decremental AV pathways is limited. 
Mettlrods. Of 759 consecutive patients with accessory pathway- 
mediated tacbvarrbythmia, 74 with decrementa! AV pai:‘:vazs 
were investigated (mean age 45 f iZ yean). F&r basdine 
eleetropbysiologic study, the serial drugs adenosine, verapamil 
and procainamide were tested during atriai and ventricular 
pacing, Finally, radiofrequency catheter ablation was performed. 
Results. Five patients bad anterograde decremental conduction 
over the accessory- pathway but had no retrograde conduction. Of 
the 64 patients with retrograde decremental conduction over the 
accessory patbvay, anterograde conduction over the pathway was 
absent in 41 (64%), intermittent in 5 (8%) and nondecremental in 
,--- 
Anterograde and retrograde conduction at a constant interval 
during incremental pacing and programmed cardiac stimula- 
tion has been considered to be characteristic of conduction 
over an accessory atrioventricuiar (Arl) pathway (1). Never- 
theless, electrophysiologic studies have shown the presence of 
accessory pathways, including nodoventricular and atriofas- 
cicular pathways, with AV node-like properties and long 
conduction times in patients with incessant AV reciprocating 
tachycardia and NIahaim fibers (2-7). However, information 
about the electrophysiologic characteristics and pharmacologic 
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18 (28%). In the remaining five patients, anterograde and retro- 
grade decremental conduction over tbe same pathway was found. 
The anterogsade and retrograde conduction properties and extent 
of decrement did not differ between anterograde and retrograde 
decremental pathways. Posteroseptal pathways had the bighest 
incidences of anterograde and retrograde decremental conduc- 
tion. Intravenous adenosine, procainamide and verapamil caused 
conduction delay or block, or both, in 10 of 10, 10 of 10 and 4 of 
18 of the anterograde and 20 of 20, 20 of 2@ and 8 of 20 of the 
retrograde decremental pathways, respectively. AlI patients bad 
suecessfui ablation of the decremental pathways without compli- 
cations. Duriog the fellow-up period of 31 f 19 months, only one 
patient experienced recurrence. 
Conclltsions. Decremental accessory patbwgs ssoally bad 
functionally distinct conduction characteristics in the anterogradr: 
and retrograde directions. Their pbarmacollcgic responses sug 
gested the ‘heterogeneous mechanisms of decremental conduction. 
@Am Co11 Cardiol1996;28:732-7) 
responses of anterograde and retrograde decremental AV 
pathways was limited and unclear (8-12). 
The purposes of this study were to characterize the functional 
properties of decremental accessory pathways and to investigate 
their responses to adenoske, verapamil and procainamide in a 
large series of patients with Wolff-~ar~nson-ate syndrome. 
Methsds 
Patient characteristics. Of the 759 consecutive patients 
with accessory pathway-mediated tachyarrhythmia referred to 
Veterans General Hospital-Taipei for electrophysiologic study 
and radiofrequency catheter ablation, 74 (9.7%) had decre- 
mental AV pathways (without Mahaim fibers) (32 male, 42 
female; mean age 43 rt 18 years, range IQ to 82). All were 
refractory to or intolerant of 2 2 1 (range. 1 to 4) antiarrhyth- 
mic drugs. The other 685 patients were designated as the 
control group for comparison. 
Electrophysiologic study. All patients were studied in the 
postabsorptive, nonsedated state after written informed con- 
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sent was obtained. Details of the electropl~ysioiog~c study were 
described previously j13,14). In brief, baseline electrophya- 
ologic studies were performed after a~tiarrh~~hmjc drugs had 
been di!~continued for at least five half-lives in all patients. ‘!& 
electrocardiogram (IX%) and femoral artery pressure were 
c~~tjn~~usly monitored throughout the procedures. In brief, 
three aultipolar catheters (interelectrode space 2 mm; Mans- 
field, Boston Scientific) were introduced from the femoral 
veins and placed in the right atrium, His bundle area and right 
ventricle for recording and stimulation, One or two orthogonal 
electrode catheter:, (Mansfield) were used for coronary sinus 
recording; these were percutaneously introduced into the 
internal jugular v&r and placed in the coronary sinus to record 
left atria1 activation. Intracardiac eiectrograms were simulta- 
neously recorded with surface ECG leads I, II and Vt on a 
multichannel oscilloscope recorder (Electronics for Medicine, 
FIG, VR-13 or MIDAS 2500) at a paper speed of 100 to 150 
mm/s using a filter frequency setting of 30 to 500 I&. 
A programmed digital stimulator (DTU mode 210 or 215, 
Bloom Associates, Ltd.) was used to deliver electrical impulses 
of 2.0 ms at twice the late diastolic threshold. The standard 
protocol included 1) atria1 and ventricular incremental pacing 
at cycle lengths ranging from just under that of sinus rhythm to 
the minimal cycle lengths maintaining AV and ventriculoatrial 
(VA) 1:l conduction, respectively; 2) single and double atria1 
extrastimuli delivered during high right atria1 peeing at one or 
two cycle lengths and during sinus rhythm; and 3) single and 
double ventricular extrastimuli delivered during right ventric- 
ular apical pacing at cycle lengths of 600 and 400 ms and during 
sinus rhythm. Left atria1 stimulation was also performed. For 
induction of atria! flutter-fibrillation, atria1 burst pacing was 
performed if atria1 extrastimuii c&? not induce flutter- 
fibrillation. Intravenous isoproterenol (1 to 4 pg/min) or 
atropine (0.02 to 0.01 mg/kg body weight), or both, was used to 
facilitate induction of tachyarrhythmias. 
~~~~aco~~g~c study. All patients with anterograde decre- 
mental pathways and 20 patients with retrograde decremental 
pathways received serial drug tests, On the first day of the 
study, adenosine and verapamil were given intravenously to 
each patient. On the third day, procainamide was administered 
intravenously. The effects of intravenous adenosine, verapamil 
and procainamide on anterogade decremental pathways were 
evaluated during atria1 pacing at a qcle length 20 ms longer 
than the shortest paced cycle length with 1:l accessory pathway 
conduction. The effects of these drugs on retrograde decre- 
mental pathway were evaluated during ventricular pacing at a 
cycle length 20 ms longer than the shortest paced cycle length 
with 1:l accessory pathway conduction. After intravenous 
infusion of verapamil and procainamide, accessory pathway 
conduction properties were evaluated again, as in previous 
protocols. 
Adenosine was injected into the femoral vein and flushed 
with 10 ml of saline. Additional incremental doses of adeno- 
sine (37.5 @g/kg body weight) were injected until block of 
accessory pathway conduction occurred (37.5 to 150 @g/kg). 
The dosage of intravenous verapamil was 0.15 mgikg body 
weight over a petiod of 2 min. Froca~a~~idc (10 t.o 12 mg’kg) 
was givers intravenously as a Xl-mg bolus every 2 min (1.5). 
~ad~nfreq~ency ablation, As described previously? a 71; 
quadripolar electrode catheter with a I-mm distal electrode 
(interelectrode space 2 mm) and a deflectable curve was used 
for ablation (X3,14). ~ad~ofreq~cncy current (generated from 
Radionic-3C) was delisereti between the tip electrode and an 
indiffen:it patch electrode positioned on the left side of the 
posterior chest wall. The unit was coupled to a device that 
provided real-time monitoring of root-mean-square voltage, 
current and impedance. The ablation techniques and biophys- 
ical variables of radiofrequency energy used in various types of 
tachycardia have been described previously (13,14). In each 
patient a possible accessory pathway potential, local efectro- 
grams showing fusion of A and V waves with the 1,’ wave earlier 
than the delta wave (for anterograde conduction) or local 
electrograms showmg the earliest A waves during ventricular 
pacing or reciprocating tachycardia (for retrograde conduc- 
tion) were used to guide the ablation catheter, After the 
ablation procedure, isoproterenol (1 to 4 &mm) was admin- 
istered 20 to 30 min later to enstre successfit results. If the 
delta wave or any tachycardia recurred, mapping and ablation 
procedures were repeated. The successful ablation sites were 
recorded in the tine films, 
DefIuitions. Ikcremental coaductkm was considered to be 
present in the accessory pathways if the following criteria were 
satisfied: 1) rate-dependent prolongation of VA or atrial-delta 
wave intervals by ~30 ms as measured in the electrogram 
nearest the accessory pathway, or 2) Wenckebach anterograde 
or retrograde block (11). In the case of septal accessory 
pathways where retrograde conduction could be confused with 
retmerade AV node conduction, atria1 pre-excitation or pro- 
long&on of the VA interval without change in the retrograde 
activation sequence after ventricular extrastimuli clclivcred 
during AV reciprocating tachycardia at a time when the His 
bundle was refractory was considered to occur over the acces- 
sory pathway (Fig. 1). For patients with intact retrograde 
conduction over the AV node, changes in the VA interval 
during ventricular pacing or extrastimulation might be mis- 
leading because of changing degrees of atriai fusion. VA 
conduction curves before and after successful ablation of the 
accessory pathway were compared to prove the decremental 
conduction of the accessory pathway. 
Retrograde decremental pathways were divided into two 
types according to the clinical presentation. The retrograde 
pathways in patients w&L permanent junctional reciprocating 
tachycardia belonged to major decremental type, and those in 
other patients belonged to minor decremental type* 
StatitisticaI anaiysis. Data were e.xpressed as mean value t 
SD. Differences in continuous variables were analyzed by the 
paired and unpaired t test, and differences in categorical 
variables were analyzed by chi-square analysis wit& the Yates 
correction or the Fisher exact test. A p value 40.05 was 
considered statistically significant. 
Clinical and electropbysiologic characteristics. Decre- 
mental conduction was present in the anterograde direction 
exciusively in 5 patients (5 pathways), retrograde direction 
exclusively in 64 patients (64 pathways) and in both directions 
in 5 patients (5 pathways). The documented tachyarrhythmias 
in these patients included AV reciprocating tachycardia (45 
patients), atrial fibrillation (5 patients), atria1 fibrillation and 
AV reciprocating tachycardia (15 patients) and the permanent 
form of junctional rccipc&g taciiycardia (9 ptk~ts). The 
clinical tachycardia was induced in all patients during electro- 
physiologic study. 
Anterograde decremental coraduction (five patients). The 
shortest atria1 paced cycle length with t:I anterograde conduc- 
tion over the accessory pathway was 306 rt 49 ms, and the 
anterograde accessory pathway effective refractory period was 
266 rt 46 ms. Retrograde conduction over the accessory 
pathway could not be demonstrated in these five patients. 
Anterograde accessory pathway conduction curves were con- 
tinuous in all pathways. The maximal protongation of atria1 
electrogram to delta wave interval was 62 t 31 ms. 
Retrograde decremental conduction (&patients). The short- 
est ventricular paced cycle length with 1:l retrograde conduc- 
tion over the accessory pathway was 332 + 93 ms, and the 
retrograde accessory pathway etfective refractory period was 
272 + 54 ms. Retrograde accessory pathway Tonduction curves 
during ventricular extrastimulus testing were continuous in all 
cases. Anterograde conduction over the accessory pathway was 
Figure X. Electrophysiologic recordings from a patient with 
a right midseptat accessq pathway. A, Progressive prolon- 
gation of the ventricu!oatria! (VA) interval from 190 to 
ZOO ms during right ventricular pacing (cycle length SO0 ms). 
B, Progressive prolongation of the VA interval from 240 to 
280 ms during right ventriclJar pacing (cycle length 350 ms). 
C, Atria1 pre-excitation by 30 ms without a change in the 
retrograde activation sequence after a premature ventricu- 
lar extrastimulus delivered during AV reciprocating tachy- 
cardia when the His bundle was refractory. HRA, HBE, 
PCS. KS, DCS and RV represent the recordings from the 
pacing electrodes in the high right atrium: the His hundle 
area: the proximal coronary sinus, the middle coronary 
sinus, the distal coronary sinus and the right ventricte, 
respectively. A = atria1 electrogram; S = stimulus; V = 
ventricular electrogram. 
absent in 41 patients (640/o), and intermittent pre-excitation 
was present in 5 patients (8%). In the remaining 18 patients 
(28%) with nondecremental anterograde conduction, the 
shortest atria1 paced cycle length with 1:l anterograde conduc- 
tion over the pathways was 332 t 96 ms, and the anterograde 
accessory pathway effective refractory period was 292 2 57 ms. 
Anterograde and retrograde conduction properties, including 
1:l conduction and effective refractory period, were not signif- 
icantly different (p > 0.05). The maxima1 prolongation of the 
VA interval was 64 + 30 ms. The anterograde conduction 
properties, retrograde conduction properties and extent of 
decrement did not differ between anterograde and retrograde 
decremental pathways (Table 1). 
Table 1. Electrophysiologic Characteristics in Patients With 
Decrementai Accessory Pathways 
Anterograde Retrograde 
Decrement Decrement 
(n = 10) (n = 64) p Vz!ue 
Anterogradc conduction 
AP I:1 (ms) 308 + 72 332 t 96 0.387 
APERP (ms) 211 t 69 292 c 57 0.268 
Retrograde conduction 
AP 1:l (ms) 272 i- 49 332 ? 93 0.1x9 
APERP (ms) 252 c 45 272 ?I 54 0.591 
Extent of decrement (ms) b3 i- 22 b4 I 30 0.642 
Data are expressed as mean value t- SD. AP = accessory pathway; AP 1:l = 
shortest paced cycle length maintaining I:1 conduction over t.hr accessory 
pathway; APERP = accessory pathway elective refractory period. 
AIMS = anteromickeptal; LFW = left free wall, PS = posteroseptai; RFW = 
right free waif. 
Decremental conduc:ion itl both anterograde and retrograde 
dire&m (‘e patients). ‘Be shortest atria1 paced cycle length 
with 1:l anterograde conduction over the accessory pathway 
was 310 ?I 97 MS, and the anterograde accessory pathway 
effective refractory period was 288 i 91 ms. The shortest 
ventricular paced cycle length maintaining I:1 retrograde 
conduction over the accessory pathway was 272 ~fr 49 ms, and 
the retrograde accessory pathway effective refractory period 
was 252 t 4.5 ms. The maximal prolongation of atria1 electro- 
gram to delta wave interval and VA interval was 58 + 18 ms 
and 72 5 23 ms, respectively. 
Compaiisons with the control group. The locations of an- 
terograde and retrograde decremental pathways were signif- 
cantly different from the locations of the pathways in the 
control group (Table 2). Anterograde decremental conduction 
occurred mostly in the posteroseptal pathways. Retrograde 
decremental conduction occurred mostly in the posteroseptal 
and right free wall pathways. 
Pharmacologic responses. Anterograde decremental pa& 
wnvs. After adenosine administration (minimal dose 4.2 t 
1.5 mg), anterograde Wenckebach conduction block of decre- 
mental pathways during atrial pacing could be demonstrated in 
all 10 patients (Fig. 2). After procainamide infusion (750 % 
18 mg), progressive prolongation of the atria1 electrogram to 
delta wave intervat was found in eight patients, and Wencke- 
bath conduction block was noted in two patients. After vera- 
pamil administration (10 t 2 mg), anterograde Wsnckebach 
conduction block of decremental pathways was found in four 
patients, and in the remaining six patients, neither ,jrolonga- 
tion of the atria1 electrogram to delta wave intzrvai nor 
conduction block was found. The shortest atrial paced cycle 
length with 1:l accessory pathway conduction and effective 
refractory period increased significantly after veiapamil and 
procainamide infusion. 
Retrograde decrenlerltalpat~~w. After adenosine adminis- 
tration (minimal dose 4.5 Ir: 1.3 mg), retrograde Wenckebach 
conduction block during veiltricular pacing was found in 18 
patients and sudden conduction block in 2 patients. After 
procainamide infusion (762 2 14 mg), progressive prolonga- 
tion of the VA interval was found in 14 patients and Wencke- 
bath conduction block in 6 patients. After verapamil adminis- 
tration (9.6 + 1.8 mg), retrograde Wenckebach conduction 
block was demonstrated in 8 patients, whereas in the remain- 
ing 12 patients, the VA interva;?l did not change. The shortest 
ventricaIar paced cj&e tength with I: 1 accessory’ pathway 
conduction and e&ective refractory period increased sign& 
cantly after verapamil and ~ro~~~~u~~~jd~ infusloo. Ccmpari- 
sons of ci~ctropfiarmacologic characteristics beLveen major 
and minor decremental pathways showed a lazges extent of 
dccrememt a longer VA interval daring ta~~~~~~rd~~ and a 
higher incidence of vera~al~lil-~0duced cor~ductian block in the 
major decrementai pathl;vay j’fable 3j. 
~~i~~r~~u~n~ abiation and clinical ~n~luw~u~, AI1 pa- 
tients had successful ablation of the decremental accessory 
pathways. No complication occurred during each ablation 
session. A suspected accessory pathway potential was recorded 
at the successfuul target site in 23 (82%>j of 28 patients with a 
manifest pathway and in 35 (76%) ol 46 patients with a 
concealed pathway or intermittent pre-excitation. In the re- 
maining 16 patients without registered accessory pathway 
potential, the A/V ratio at the successful ablnlion site was 
0.28 I 0.16 for manifest pathways: and the ‘;:)A ratio was 
3.54 L 2.62 for concealed pathways. The mean pulse number 
was 5 1: 4, the fluoroscopy time was 36 2 2i min and the total 
procedure time was 2.8 i- 1.4 h. After ablation, no reciprocat- 
ing tachycardia was induced, but atria1 fibrillction was stil 
inducible in 6 of 20 patients with a clinical histo? of this 
arrhythmia. 
During the follow-up period of 31 2 19 months (range 4 to 
68), only one patient experienced recurrence of accessory 
pathway conduction with reciprocating trichycardia. She had a 
successful result during the second abiation procedure. 
Ma&r findings. The incidence of decremental accessory 
pathways in patients with Wolf-~ar~nson-W~te syndrome 
was 9.7%. However, decremental conduction rarely occurred 
in both the anterograde and retrograde directions within the 
same pathway (0.796). Posteroseptat pathways had the highest 
incldences of ankiograde and retrograde decremental conduc- 
tion. Adenosine and procai;umtide had a direct inhibitoq 
effect on decremental patkay conduction, whereas verapa- 
milk inhibitory effect was less. 
~l~ctro~~~sio~~g~~ eharaeterisrics and pathway locatians. 
Decremental conduction over an accessory pathway had typi- 
cally been associated with the presence of Mahaim fibers and 
the permanent form of junctional reciprocating tachycardia, 
but it was reported infrequently in patients with paroxysmal 
AV reciprocating tachycardia. Gillette et al. (9) 51% reported 
four patients who had right anterior accessory connections 
with iong conduction times and decremental conduction and 
recurrent wide QRS tachycardia. These workers suggested that 
these pathways represent the remnants of anterior -4V node 
tissue (9). Centurion et al. (1Oj have demonstrated that in 
left-sided AV pathways, 7% of anterograde GJnduction and 
15” IC of retrograde conduction bad decremental conduction 
(maximal decrement 230 ms). Murdork et al. (It) have shown 
that the incidence of decremental accessory pathways was 
7.6%; right parietal pathways had the highest incidence of 
anxerograde decremental conduction, arid left parietai path- 
ways had the highest incidence of retrograde decremental 
conduction. 
In the present study, a clinical pattern consistent with the 
permanent form of junctional reciprocating t.;chycardia was 
present in 9 patients (12%). In the remaining 65 patients, 
paroxysmal AV reciprocating tachycardia or atrial fibrillation, 
or both, was found. The former had a larger extent of 
decrement and a longer VA interval during reciprocating 
tachycardia. Posteroseptal pathways had the highest incidences 
of anterograde and retrograde decremental conduction. How- 
ever, decremental conduction rare$ occurred in both the 
anterograde and retrograde directions within the sdme path- 
way. Although decremental conduction was present in one 
direction, conduction was often absent in the other. These 
findings suggest that conduction over the accessory pathway in 
anterograde and retrograde directions may be functionally 
distinct. 
Electro@armacol~gic haracteristics. In the present study, 
adenosine infusion produced conduction block in all decremental 
pathways, and procainamide infusion prolonged the effective 
refractory periods and conduction times of these pdthw;iyS, 
whel-eas verapamil had a direct inhibitory effect on these path- 
ways in only 12 of 30 patients (40%). The direct effects of 
adenosine have been demonstrated to result in activation of the 
potassium current, which hyperpolarizes the cell membrane to 
Ilear EK and depresses the action potential in the AV node cells 
Table 3. Compariscms of Electrophysiologic Chracteristics 
and Pharmacologic Responses Between Major and Minor 
Decremental Pathways - 1_- 
Major Minor 
(n = 9) (II = 60) p Value - 
Tiichycardia CL (ms) 410 2 35 406 t 32 0.642 
Retrograde AP I :l (ms) 320 f 92 335 t 96 0.856 
Extent of decrement (ms) 82 f 26 60 + 24 0.015 
VA interval during tachycardia (ms) 302 ir 17 275 t 20 O.Kii 
VA prolongation or VA block 
Adenosine 515 (100) ’ 1 151 3 (loo) O.lG?J 
Pracainamide 515 (IN) 15115 (100) 0.109 
Verapamil 45 (83) 4115 (26) 0.033 
Data are expressed as mean value C SD or number (%) of patients. AP = 
accessory pathway: CL = cycle length; VA = ventriculoatrial. 
(16). Because adenosine produced conduction block in all decre- 
mental pathways in this study, it was proposed that decremental 
conduction is due to partial depolarization in the anomalous atria1 
fascicles (12). This hypothesis is also consistent with previous 
o*bsemations in which adenosine was found to have no effect on 
normdly conducting, nondecremental accessory pathways with 
rest membrane poteniial near E, (17). Previous repow hziiiz 
demonstrated that procainamide may impair or abolish antero- 
grade conduction over accesso;-p pathways and has more marked 
etXects on anterograde than on retrograde accessory pathway 
refractoriness (15,18-20). In the present study, procaina- 
mide was equally effective in impairing or blocking antero- 
grade and retrograde decremental pathways and major and 
minor decremental pathways. These adenosine-seCtive and 
procainamide-sensitive characteristics suggest that Iha: decre- 
mental AV pathways were mainly composed of tiepressed 
fast-channel fibers. In Lontrast, only some of the decremental 
AV pathways, especially those with permanent junctional 
reciprocating tachycardia (major decremental pathways), had 
responses to verapamil, which is a calcium channel blocking 
agent. This finding might suggest that major decremental AV 
pathways consist of more slow-channel fibers (Ai’ node-like 
cells) than do minor decremental pathways (X-24). Further- 
more, this may explain why the major decremental pathways 
had a larger extent of decrement and a longer VA interval 
during reciprocating tachycardia. 
Possible mechanisms of decremental conduction. The ex- 
planation for the occurrence of decrement over an accessory 
pathway is not known. Several possible mechanisms have been 
proposed: 1) In the present study and in previously reported 
cases, pcsteroseptal pathways located 51 close proximity to the 
AV node had the highest incidence of decremental conduc- 
tion. raising the possibility that the pathway is an AV node-like 
structure (22,23): Furthermore, previous pathologic studies in 
patients with decrementally conducting accessory pathways 
showed that AV node-like cells were identified in some cases 
(24). 2j Decremental conduction over the accessory pathways 
in one direction but not in the other may be due to accessory 
pathway geometry or accessory pathway fiber orientation. 
!%tho~ogic examination of septal accessoiy pathways in pa- 
tients with the permanent form of junctional reciprocating 
tachycardia has demonstrated that the accessory pathway took 
a tortuous course with a concomitant change in axial resis- 
tance, providing further support that accessory pathway geom- 
etry may contribute to decremental conduction (5). 3) A role 
for impedance mismatch between the accessory pa:hway and 
the atrium or ventricle has also been suggested (25,26). 
Study l~mjtatj~~s. Because ihe rate of adrn~n~strat~o~~ of 
procainamide was cautiously slow in the present study, this 
minimized the opportur&y for causing block in the accessory 
pathway. With rapid infusion rate (e.g., ~100 ~n~~llin), con- 
duction block might occur at the time of peak plasma leve!s 
(27). The present study did not determine the site of conduc- 
tion delay; atria1 and ventricular pacing maneuvers could be 
helpful when pathway potentials were registered. 
Conclusions. Decremental accessory pathways were not 
common in patients with Wolff-Parkinson-White syndrome. 
These pathways usually had functionally distinct conduction 
characteristics in the anterograde and retrograde directions. 
Most decremental pathways were located in the posteroseptal 
area. Adenosine and procainamide had a direct inhibitory 
effect on these pathways, but verapamil’s inhibitory effect was 
less. 
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